Genetic polymorphisms and drug metabolism
<p><strong>Background:</strong> It is estimated that genetic factors account for 15–30 % of variability in drug response, however for some drugs this may be the major determinant in drug response. Pharmacogenetics aims to identify genetic sources of variability in response to drugs...
Main Author: | Vita Dolžan |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2007-12-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/1976 |
Similar Items
-
Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective
by: Gurusamy Umamaheswaran, et al.
Published: (2014-01-01) -
Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder
by: Rafał Świechowski, et al.
Published: (2019-06-01) -
e-PKGene: A knowledge-based research tool for analysing the impact of genetics on drug exposure
by: Hachad Houda, et al.
Published: (2011-07-01) -
CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
by: Immaculate M. Langmia, et al.
Published: (2021-07-01) -
Towards Accurate Genotype–Phenotype Correlations in the CYP2D6 Gene
by: Angel L. Pey
Published: (2020-10-01)